cumyl-PINACA
a synthetic cannabinoid; structure in first source
Also Known As:
1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Banister, Samuel D:
2 articles
(02/2019 - 10/2017)
|
2. | Boyd, Rochelle:
2 articles
(02/2019 - 10/2017)
|
3. | Connor, Mark:
2 articles
(02/2019 - 10/2017)
|
4. | Kevin, Richard C:
2 articles
(02/2019 - 10/2017)
|
5. | McGregor, Iain S:
2 articles
(02/2019 - 10/2017)
|
6. | Adams, Axel:
1 article
(02/2019)
|
7. | Barratt, Monica J:
1 article
(02/2019)
|
8. | Bright, Stephen J:
1 article
(02/2019)
|
9. | Gerona, Roy R:
1 article
(02/2019)
|
10. | Glass, Michelle:
1 article
(02/2019)
|
Related Diseases
1. | Pica (Geophagia)
02/01/2019
- " Despite CB1 binding affinities differing by over two orders of magnitude (Ki = 2.95-174 nM), all compounds were potent and efficacious CB1 agonists (EC50 = 0.43-4.7 nM), with consistent rank order for binding and functional activity (5F-CUMYL-PINACA >5F-CUMYL-PICA >5F-CUMYL-P7AICA). " 10/18/2017
- " Herein we describe the synthesis, characterization, and pharmacology of SCs CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-PINACA, CUMYL-5F-PINACA, and related analogues. " 01/01/2023
- " Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA."
|
2. | Poisoning
|
|
Related Drugs and Biologics